Heather Rowe Armstrong Joins Arcutis as Vice President of Investor Relations and Corporate CommunicationsGlobeNewsWire • 03/05/20
Arcutis Announces Data from the Phase 2b Study of Topical Roflumilast Cream in Patients with Plaque Psoriasis Selected for Late-Breaking Oral Presentation at the American Academy of Dermatology (AAD) Annual MeetingGlobeNewsWire • 03/03/20
Arcutis Announces Enrollment of First Patient in Topical Roflumilast Cream Phase 3 Open Label Extension Study in Plaque PsoriasisGlobeNewsWire • 02/13/20